Save your place

Sign in to WhoBought

Please try again later.

Protagonist Therapeutics, Inc. (PTGX) institutional ownership

Latest close $135.43 Jul 23, 2026
Market cap$3.3B 52-week range SectorHealthcare
Funds holding · Q1 2026
307
reported PTGX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
157 buyers · 150 sellers

Protagonist Therapeutics, Inc. (PTGX) price and institutional activity

Dates

Q1 2026

$0 bought by 157 investors
UBS Group AGVanguard +155 more
$0 sold by 150 investors
Commodore Capital LPMarshall Wace, LLP +148 more
Bought Sold Totals per quarter; hover a bar for the names.

Protagonist Therapeutics, Inc. (PTGX) institutional activity · 307

Investor Type Est. change Change Δ Own Date
UBS Group AG · Added
Change +2.4M Date Q1 2026
UBS Group AG Added· Q1 2026 +2.4M Q1 2026
Vanguard · Added
Change +1.4M Date Q1 2026
Vanguard Added· Q1 2026 +1.4M Q1 2026
Hood River Capital Management LLC · New
Change +829K Date Q1 2026
Hood River Capital Management LLC New· Q1 2026 +829K Q1 2026
Jennison Associates LLC · Added
Change +741K Date Q1 2026
Jennison Associates LLC Added· Q1 2026 +741K Q1 2026
Invesco Ltd. · Added
Change +597K Δ Own +38.1% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +597K +38.1% Q1 2026
Commodore Capital LP · Exited
Change −450K Δ Own −100.0% Date Q1 2026
Commodore Capital LP Exited· Q1 2026 −450K −100.0% Q1 2026
Wellington Management Group LLP · Added
Change +428K Δ Own +13.5% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +428K +13.5% Q1 2026
Rubric Capital Management LP · New
Change +428K Date Q1 2026
Rubric Capital Management LP New· Q1 2026 +428K Q1 2026
Bank of America Corp · Added
Change +428K Date Q1 2026
Bank of America Corp Added· Q1 2026 +428K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +425K +37.7% Q1 2026
Marshall Wace, LLP · Reduced
Change −397K Date Q1 2026
Marshall Wace, LLP Reduced· Q1 2026 −397K Q1 2026
Alyeska Investment Group, L.P. · Added
Change +394K Date Q1 2026
Alyeska Investment Group, L.P. Added· Q1 2026 +394K Q1 2026
Driehaus Capital Management LLC · Reduced
Change −378K Date Q1 2026
Driehaus Capital Management LLC Reduced· Q1 2026 −378K Q1 2026
Vestal Point Capital, LP · New
Change +326K Date Q1 2026
Vestal Point Capital, LP New· Q1 2026 +326K Q1 2026
T. Rowe Price Associates · Added
Change +265K Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +265K Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 307

Famous investor activity in Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics, Inc. (PTGX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Waddill William D. · Director Sell −$1.1M
Price $117.94 Qty −9K Owned 8K ΔOwn −53.5% Trade date Jun 23, 2026 Filed date Jun 25, 2026
Waddill William D. Director Sell $117.94 −9K −$1.1M 8K −53.5% Jun 23, 2026 Jun 25, 2026
Waddill William D. · Director 2 operations 0
Price $16.54 Owned 0 Trade date Jun 23, 2026 Filed date Jun 25, 2026
Waddill William D. Director 2 operations $16.54 0 0 Jun 23, 2026 Jun 25, 2026
Waddill William D. · Director Sell −$969K
Price $107.68 Qty −9K Owned 8K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Waddill William D. Director Sell $107.68 −9K −$969K 8K Jun 10, 2026 Jun 11, 2026
Waddill William D. · Director 4 operations 0
Price $11.80–$16.54 Owned 9K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Waddill William D. Director 4 operations $11.80–$16.54 0 9K Jun 10, 2026 Jun 11, 2026
Waddill William D. · Director Sell −$897K
Price $99.64 Qty −9K Owned 8K Trade date May 29, 2026 Filed date Jun 1, 2026
Waddill William D. Director Sell $99.64 −9K −$897K 8K May 29, 2026 Jun 1, 2026
Waddill William D. · Director 2 operations 0
Price $11.80 Owned 3K Trade date May 29, 2026 Filed date Jun 1, 2026
Waddill William D. Director 2 operations $11.80 0 3K May 29, 2026 Jun 1, 2026
Patel Dinesh V Ph D · Director Sell −$7.5M
Price $100.12 Qty −75K Owned 523K Trade date May 12, 2026 Filed date May 12, 2026
Patel Dinesh V Ph D Director Sell $100.12 −75K −$7.5M 523K May 12, 2026 May 12, 2026
Patel Dinesh V Ph D · Director 2 operations 0
Price $21.58 Owned 225K Trade date May 12, 2026 Filed date May 12, 2026
Patel Dinesh V Ph D Director 2 operations $21.58 0 225K May 12, 2026 May 12, 2026
Giraudo Bryan · Director 2 operations −$1.1M
Price $100.00 Qty −11K Owned 13K Trade date May 8, 2026 Filed date May 11, 2026
Giraudo Bryan Director 2 operations $100.00 −11K −$1.1M 13K May 8, 2026 May 11, 2026
Giraudo Bryan · Director 2 operations −$4.8M
Price $100.07–$100.14 Qty −48K Owned 6K Trade date May 7, 2026 Filed date May 11, 2026
Giraudo Bryan Director 2 operations $100.07–$100.14 −48K −$4.8M 6K May 7, 2026 May 11, 2026
Giraudo Bryan · Director 4 operations 0
Price $6.45–$6.98 Owned 0 Trade date May 7, 2026 Filed date May 11, 2026
Giraudo Bryan Director 4 operations $6.45–$6.98 0 0 May 7, 2026 May 11, 2026
Patel Dinesh V Ph D · Director Gift (G) -1K
Owned 523K Trade date Apr 23, 2026 Filed date Apr 24, 2026
Patel Dinesh V Ph D Director Gift (G) -1K 523K Apr 23, 2026 Apr 24, 2026
Ali Asif · CFO Sell −$185K
Price $105.47 Qty −2K Owned 59K Trade date Apr 20, 2026 Filed date Apr 21, 2026
Ali Asif CFO Sell $105.47 −2K −$185K 59K Apr 20, 2026 Apr 21, 2026
Molina Arturo Md · Officer Sell −$1.6M
Price $104.79 Qty −15K Owned 84K Trade date Mar 26, 2026 Filed date Mar 27, 2026
Molina Arturo Md Officer Sell $104.79 −15K −$1.6M 84K Mar 26, 2026 Mar 27, 2026
Molina Arturo Md · Officer 2 operations 0
Price $8.04 Owned 51K Trade date Mar 26, 2026 Filed date Mar 27, 2026
Molina Arturo Md Officer 2 operations $8.04 0 51K Mar 26, 2026 Mar 27, 2026
15 of 62
15 of 62 Sign in to continue to older insider transactions.

Protagonist Therapeutics, Inc. (PTGX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Biotechnology Value Fund L P 1.5M
% of shares outstanding 15223930.0% Filing date Nov 14, 2024
Biotechnology Value Fund L P 1.5M 15223930.0% Nov 14, 2024
BlackRock Inc. 10.7M
% of shares outstanding 18.2% Filing date Aug 7, 2024
BlackRock Inc. 10.7M 18.2% Aug 7, 2024
Rtw Investments, LP 5.3M
% of shares outstanding 9.2% Filing date Feb 14, 2024
Rtw Investments, LP 5.3M 9.2% Feb 14, 2024
Vanguard Group Inc 4.2M
% of shares outstanding 7.2% Filing date Nov 12, 2024
Vanguard Group Inc 4.2M 7.2% Nov 12, 2024
Vanguard Portfolio Management 3.5M
% of shares outstanding 5.5% Filing date Apr 29, 2026
Vanguard Portfolio Management 3.5M 5.5% Apr 29, 2026
Vanguard Capital Management 3.3M
% of shares outstanding 5.1% Filing date Apr 30, 2026
Vanguard Capital Management 3.3M 5.1% Apr 30, 2026
State Street Corporation 3.1M
% of shares outstanding 4.9% Filing date May 12, 2026
State Street Corporation 3.1M 4.9% May 12, 2026
Point72 Asset Management, L.P. 2.6M
% of shares outstanding 4.5% Filing date Feb 14, 2024
Point72 Asset Management, L.P. 2.6M 4.5% Feb 14, 2024
8 of 10

Protagonist Therapeutics, Inc. (PTGX) ownership FAQ

Who owns PTGX?

307 reporting institutions disclosed PTGX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.